Dietary essential fatty acids, vitamin E, and Charcot-Marie-Tooth disease

Neurology

Volumn 36, Issue 9, 1986, Pages 1200-1205

  Williams, Lowell L ^a   O’Dougherty, Margaret M ^a   Wright, Francis S ^a   Bobulski, Rosalind J ^a   Horrocks, Lloyd A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; INDOMETACIN; LINOLEIC ACID; OLEIC ACID; PLACEBO;

CLINICAL ARTICLE; DIET; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MUSCLE; MUSCULOSKELETAL SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SERUM; THERAPY;

ADOLESCENT; ADULT; ARACHIDONIC ACIDS; CHARCOT-MARIE-TOOTH DISEASE; FATTY ACIDS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUSCULAR ATROPHY; NEUROPSYCHOLOGICAL TESTS; VITAMIN E;

EID: 0022540504     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.36.9.1200     Document Type: Article

References (27)

1. Yao JK, Ellefson RD, Dyck PJ. Lipid abnormalities in hereditary neuropathy. I. Serum non-polar lipids. J Neurol Sci 1976;29:161–75.
2. Yao JK, Dyck PJ. Lipid abnormalities in hereditary neuropathy. II. J Neuro Sci 1978;36:225–36.
3. Dyck PJ. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, vol 2. Philadelphia: WB Saunders, 1984:1600–41.
4. Meade CJ, Mertin J, Shenna J, Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci 1978;35:291–308.
5. Ip SHC, Abrahm J, Cooper RA. Enhancement of blastogenesis in cholesterol-enriched lymphocytes. J Immunol 1980;124:87–93.
6. Goetzl EJ. Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 1981;65:809–28.
7. Williams LL, Penn GM. Selective IgA deficiency in Charcot-Marie-Tooth disease. Am J Clin Pathol 1979;72:8100–6.
8. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 1982;57:239–46.
9. Urbanek K, Jansa P. Cellular inflammatory response: findings in patients with neurological disorders. Arch Neurol 1974;30:372–4.
10. Williams LL, Shannon BT. Lymphocyte suppressor activity in Charcot-Mane-Tooth disease. Abstract. Neurology (Cleveland) 1984;34(suppl 1):79A.
11. Goodwin JS, Bankhurst AD, Messner RP. Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 1977;146:1719–32.
12. Swaiman KF, Wright FS. Pediatric neuromuscular diseases. St. Louis: CV Mosby, 1979:38–43.
13. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590–6.
14. Baker RWR, Thompson RHS, Zilkha KJ. Serum fatty acids in multiple sclerosis. J Neurol Neurosurg Psychiatry 1964;27:408–14.
15. Williams LL, O’Dougherty MM, Wright FS, Bobulaki RJ, Horrocks LA. Essential fatty acid dietary addition in hereditary neuropathy. Prog Lipid Res 1986 (in press).
16. Hill EG, Johnson SB, Lawson LD, Mahfouz MM, Holman RT. Perturbation of the metabolism of essential fatty acids by dietary partially hydrogenated vegetable oil. Proc Natl Acad Sci USA 1982;79:953–7.
17. Ilonen J, Reunanen M, Salmi A, Herva E. Lymphocyte blast transformation response to mitogen and specific antigens in different clinical phases of multiple sclerosis. Acta Neurol Scand 1983;68:1–12.
18. Williams LL. Pyruvate oxidation in Charcot-Marie-Tooth disease. Neurology (NY) 1979;29:1492–8.
19. Biology of vitamin E. Ciba Foundation Symposium 101. London: Pitman, 1983.
20. Muller DPR, Lloyd JK, Wolff OH. Vitamin E and neurological function. Lancet 1983;1:225–8.
21. Bates D, Fawcett PRW, Shaw DA, Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 1978;2:1390–1.
22. Paty DW. Double blind trial of linoleic acid in multiple sclerosis. Arch Neurol 1983;40:693–4.
23. Offner H, Clausen J. Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acids and prostaglandins in multiple sclerosis. Lancet 1974;2:1204–5.
24. Rice GPA, Finney D, Braheny SL, Knobler RL, Sipe JC, Oldstone MBA. Disease activity markers in multiple sclerosis. J Neuroimmunol 1984;6:75–84.
25. Galli C, Agradi E, Petroni A, Socini A. Modulation of prostaglandin production in tissues by dietary essential fatty acids. Acta Med Scand [Suppl] 1980;642:171–9.
26. Schultz AM, Henderson LE, Oroszlan S, Garber EA, Hanafusa H. Amino terminal myristylation of the protein kinase p60src. a retroviral transforming protein. Science 1985;227:427–9.
27. Tinoco J, Babcock R, Hincenbergs I, Medwadowski B, Miljanich P, Williams MA. Linolenic acid deficiency. Lipids 1983;14:166–73.